…
Frequency Exchange Corp. focuses on the development and commercialization of a wearable frequency delivery system that provides programs for health, wellness, and performance enhancement. The company is headquartered in Vancouver, Canada. Frequency Exchange Corp. operates as a subsidiary of Waveforce Electronics Inc.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Frequency Exchange Corp. (FREQ.V) is limited and the company's core business is not clearly disclosed in available filings. Long-term growth drivers are not well documented and would depend on management articulating a credible strategy, successful execution and securing adequate financing; investors may find the stock of interest if those elements become evident.
Primary risks include lack of disclosure, illiquid TSX Venture listing, early-stage or undefined operations, significant execution and financing risk, and typical small-cap governance and market-structure vulnerabilities.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -1.18M | -1.44M | -4.86M | -0.78M | -0.12M |
| Net income | -1.18M | -1.44M | -4.86M | -0.78M | -0.12M |
| Selling general administrative | 1.32M | 1.42M | 2.52M | 0.91M | 0.12M |
| Gross profit | 0.71M | 0.51M | 0.43M | 0.32M | - |
| Reconciled depreciation | 0.03M | 0.04M | 0.03M | 0.02M | - |
| Ebit | - | - | - | -0.61M | -0.46M |
| Ebitda | - | - | -4.73M | -0.60M | -0.12M |
| Operating income | -1.14M | -1.42M | -2.39M | -0.63M | -0.12M |
| Interest expense | 0.04M | 0.05M | 0.10M | 0.16M | - |
| Interest income | 0.01M | 0.03M | 0.02M | 0.01M | 0.00M |
| Net interest income | -0.04M | -0.03M | -0.08M | -0.15M | 0.00M |
| Total revenue | 1.05M | 0.83M | 0.70M | 0.85M | 0.00M |
| Total operating expenses | 2.19M | 2.25M | 3.09M | 1.47M | 0.12M |
| Cost of revenue | 0.33M | 0.32M | 0.26M | 0.52M | - |
| Total other income expense net | -0.00M | 0.01M | -2.39M | - | - |
| Net income from continuing ops | -1.18M | -1.44M | -4.86M | -0.78M | -0.12M |
| Net income applicable to common shares | - | - | - | -0.76M | -0.50M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 0.60M | 0.37M | 1.40M | 0.51M | 0.43M |
| Intangible assets | 0.10M | 0.13M | 0.16M | 0.02M | - |
| Total liab | 1.05M | 0.89M | 1.06M | 0.20M | 0.02M |
| Total stockholder equity | -0.44M | -0.52M | 0.33M | 0.31M | 0.41M |
| Other current liab | - | - | - | 1.53M | 1.41M |
| Common stock | - | - | - | 0.00M | 0.00M |
| Capital stock | 7.40M | 6.59M | 6.35M | 0.48M | 0.48M |
| Retained earnings | -9.59M | -8.41M | -6.98M | -2.10M | -1.34M |
| Other assets | - | - | - | 0.02M | 0.02M |
| Cash | 0.34M | 0.13M | 0.96M | 0.39M | 0.43M |
| Total current liabilities | 1.00M | 0.84M | 1.06M | 2.32M | 1.61M |
| Net debt | 0.31M | 0.47M | - | 0.45M | - |
| Short long term debt | 0.60M | 0.55M | 0.73M | 0.57M | - |
| Property plant equipment | - | - | - | 0.02M | 0.03M |
| Total current assets | 0.50M | 0.24M | 1.23M | 0.33M | 0.22M |
| Net tangible assets | - | - | - | -2.01M | -1.37M |
| Net receivables | 0.01M | 0.00M | 0.00M | 0.04M | 0.08M |
| Long term debt | 0.05M | 0.05M | - | 0.05M | - |
| Inventory | 0.04M | 0.09M | 0.20M | 0.11M | 0.00M |
| Accounts payable | 0.35M | 0.21M | 0.16M | 0.17M | 0.12M |
| Non current assets total | 0.10M | 0.13M | 0.16M | 0.09M | 0.00M |
| Capital lease obligations | - | - | 0.00M | 0.02M | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -0.01M | 0.00M | -0.15M | -0.12M | - |
| Change to liabilities | - | - | - | 0.08M | -0.02M |
| Total cashflows from investing activities | - | - | - | -0.00M | -0.04M |
| Net borrowings | 0.00M | -0.14M | - | 0.46M | -0.02M |
| Total cash from financing activities | 0.89M | 0.30M | 2.43M | 0.46M | -0.02M |
| Change to operating activities | - | - | - | 0.12M | 0.56M |
| Net income | -1.18M | -1.44M | -4.86M | -0.76M | -0.50M |
| Change in cash | 0.20M | -0.83M | 0.78M | 0.03M | -0.06M |
| Begin period cash flow | 0.13M | 0.96M | 0.17M | 0.43M | 0.10M |
| End period cash flow | 0.34M | 0.13M | 0.96M | 0.39M | 0.43M |
| Total cash from operating activities | -0.68M | -1.13M | -1.50M | -0.43M | 0.00M |
| Issuance of capital stock | 0.74M | 0.47M | 2.54M | 0.00M | 0.39M |
| Depreciation | 0.03M | 0.04M | 0.03M | 0.02M | 0.01M |
| Other cashflows from investing activities | - | - | - | - | -0.02M |
| Dividends paid | 0.00M | 0.00M | - | - | - |
| Change to inventory | 0.05M | 0.11M | -0.09M | -0.11M | -0.00M |
| Change to account receivables | - | - | - | 0.03M | -0.04M |
| Change to netincome | - | - | - | 0.20M | 0.00M |
| Capital expenditures | 0.01M | 0.00M | 0.15M | 0.00M | 0.00M |
| Change in working capital | 0.08M | 0.13M | 0.20M | 0.06M | 0.02M |
| Stock based compensation | 0.35M | 0.11M | 0.64M | 0.04M | 0.04M |
| Other non cash items | 0.04M | 0.03M | 2.48M | 0.18M | - |
| Free cash flow | -0.68M | -1.13M | -1.65M | -0.04M | -0.06M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| FREQ Frequency Exchange Corp. |
- -% |
0.26 | - | - | 18.09 | 17.34 | 17.05 | -3.99 |
| TLT Theralase Technologies Inc. |
0.01 2.78% |
0.18 | - | - | 90.07 | 82.51 | 90.31 | -12.06 |
| CNVI Conavi Medical Corp. |
-0.01 4.55% |
0.10 | - | - | 66.65 | - | 95.30 | - |
| PINK Perimeter Medical Imaging AI Inc |
- -% |
0.18 | 4.13 | - | 18.78 | 11.34 | 20.22 | -2.55 |
| CHER Cheelcare Inc. |
- -% |
1.25 | - | - | 20.92 | 106.42 | 21.26 | - |
Frequency Exchange Corp. focuses on the development and commercialization of a wearable frequency delivery system that provides programs for health, wellness, and performance enhancement. The company is headquartered in Vancouver, Canada. Frequency Exchange Corp. operates as a subsidiary of Waveforce Electronics Inc.
1055 West Georgia Street, Vancouver, BC, Canada, V6E 3P3
250-732-7170
| Name | Title | Year Born |
|---|---|---|
| Mr. Stephen Davis | Chairman & CEO | 1958 |
| Ms. Nicole Sullivan | Pres & Director | NA |
| Mr. Hari B. Varshney FCA, FCPA, O.B.C. | CFO, Corp. Sec. & Director | 1943 |
| Mr. Stephen Davis | Chairman, President & CEO | 1958 |
| Mr. Hari B. Varshney FCA, FCPA, O.B.C. | CFO, Corporate Secretary & Director | 1943 |
| Mr. Dale R. MacClean M.B.A. | Member of Strategic Advisory Board | NA |
| Ms. Alexandra Moresco | Public Relations & Social Media Director | NA |
| Mr. Jeffery Barnes | Chief Marketing Officer of FREmedica Technologies Inc. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.